Basic Symmetrel Information

• INN (International Nonproprietary Name): Amantadine hydrochloride
• Brand Names Available In United Kingdom: SYMMETREL (listed for USA, CA, UK, NZ, AU) — commonly supplied as 100 mg tablets; syrup 50 mg/5 mL available in some markets.
• ATC Code: N04BB — amantadine (N: Nervous System; N04: Anti‑Parkinson Drugs; N04B: Dopaminergic Agents; N04BB: Adamantane Derivatives)
• Forms & Dosages: Tablet 100 mg; standard capsules 100 mg; extended‑release preparations available in other regions (examples 68.5 mg, 129 mg, 137 mg); syrup 50 mg/5 mL noted in some countries.
• Manufacturers In United Kingdom: not specified (manufacturers/suppliers listed in source include Endo Pharmaceuticals, Adamas Pharma, Osmotica, Merz Pharma, HEXAL, KRKA; local UK manufacturer details not specified).
• Registration Status In United Kingdom: SYMMETREL is listed among brand-country entries including the UK; the product is marketed in various countries and is prescription‑only under regulatory frameworks.
• OTC / Rx Classification: Prescription‑only (Rx) — amantadine hydrochloride is regulated as a prescription medicine globally.

Initial Instructions, Warnings And Daily-Life Integration

Worried about how to start Symmetrel safely and what to do day to day?

• Prescription Requirement & Sourcing: Symmetrel (amantadine hydrochloride) is prescription‑only under MHRA regulation in the UK; only take what your GP or neurologist prescribes.
• Pharmacies such as Boots, LloydsPharmacy, Superdrug and GPhC‑registered community or online pharmacies will dispense against a valid prescription.
• Check the product form before leaving the pharmacy — 100 mg tablets are common; syrup 50 mg/5 mL is less common.
• Immediate Warnings: Stop the medicine and seek urgent advice for severe confusion, new or worsening hallucinations, new seizures, a fast or irregular heartbeat, or signs of allergic reaction.
• Do not take amantadine if you have untreated angle‑closure glaucoma or a known allergy to amantadine or its excipients.
• Daily‑Life Integration Checklist: carry a card listing the drug and dose, store at room temperature (15–30°C) away from light, and return unused medicine to an NHS pharmacy for safe disposal.
• Report suspected side effects via the MHRA Yellow Card scheme.
• Practical Tip: Discuss driving, work safety and repeat prescriptions with your GP or community pharmacist; prescriptions are free in Scotland, Wales and Northern Ireland but usually chargeable per item in England — check current NHS guidance.

Everyday Use And Best Practices

How should Symmetrel be scheduled so it helps your Parkinson’s symptoms without disrupting sleep?

Morning Vs Evening Dosing

Many UK clinicians favour starting amantadine in the morning to reduce daytime motor symptoms and avoid sleep disturbance.

Typical adult regimens are 100 mg once daily or 100 mg twice daily with titration according to benefit and tolerability, and some regimens report doses up to 400 mg/day under specialist oversight.

If amantadine causes insomnia or agitation, take the larger dose in the morning and, if a second dose is needed, give it at lunchtime rather than late afternoon.

For antiviral use (historical Influenza A guidance) the usual short course is 100 mg twice daily for 5–7 days, started within 48 hours of symptom onset.

Taking With Or Without Meals (UK Diet Habits)

Amantadine may be taken with or without food.

Taking tablets with a heavier UK breakfast such as porridge or toast can reduce mild gastrointestinal upset.

Avoid taking a bedtime dose immediately after a large alcoholic drink because alcohol can increase dizziness and sedation.

Practical dosing rules: start low, watch for benefit within days to weeks for motor symptoms, and report sleep disturbance promptly to your prescriber.

Safety Priorities

Who should not take Symmetrel, and what activities should you avoid while taking it?

Who Should Avoid It (MHRA Warnings)

Do not use amantadine in anyone with a known allergy to amantadine or product excipients or with untreated angle‑closure glaucoma.

Use with caution and specialist input in people with seizure disorders, significant renal impairment, severe heart failure, or a history of psychosis or hallucinations.

Pregnancy and breastfeeding require specialist risk‑benefit review; elderly patients are at higher risk of central nervous system effects and orthostatic hypotension, so start low and monitor closely.

Activities To Limit (Driving, Work Safety)

Amantadine can cause dizziness, blurred vision, sleepiness and confusion.

Do not drive or operate heavy machinery if affected; follow DVLA guidance if medication causes loss of concentration or new seizures.

Inform employers or occupational health if you are in a safety‑critical role; a concise card for employers/GP can be useful.

• Red‑Flag Checklist: stop driving if you experience dizziness, confusion, hallucinations or seizures.
• Keep a concise card stating: "Taking amantadine (Symmetrel) — may cause dizziness, drowsiness, confusion; contact GP/pharmacist for details."

Dosage And Adjustments

What is the standard dosing and how should it be adjusted for older people or kidney problems?

General Regimen (NHS Guidance)

For Parkinson’s the usual starting dose is 100 mg once daily or 100 mg twice daily, with titration guided by response and side effects.

For Influenza A treatment historically, 100 mg twice daily for 5–7 days is standard if started early; antiviral use is now limited by resistance patterns.

If a dose is missed, take it as soon as remembered unless it is near the next dose; never double up to make up a missed dose.

Special Cases (Elderly, Comorbidities)

Amantadine is mainly renally excreted; reduce the dose by around 50% or increase dosing interval in renal impairment to avoid accumulation and toxicity.

Elderly patients often start at 100 mg/day with slow increases only if tolerated.

Paediatric use is specialist‑led; product data supports use from approximately 5 years in some settings with adjusted dosing.

Renal‑Adjustment Checklist For Prescribers: check eGFR, consider 50% dose reduction, monitor for CNS and cardiac adverse events.

User Testimonials

What do UK patients say about Symmetrel—does it help, and what problems do they report?

Positive Reports From UK Patients

Many forum posts and patient comments note reduced tremor and modest improvements in bradykinesia or daytime fatigue for some users.

Some patients notice benefit within days for motor symptoms, and most report no perceptible difference between branded and generic forms when strength and formulation match.

Common Challenges

Common patient‑reported issues include insomnia, vivid dreams, anxiety, dry mouth and skin mottling (livedo reticularis).

Older adults frequently report urinary difficulty, confusion or increased falls risk.

• Positives: reduced tremor, improved mobility, possible quicker onset of effect for motor symptoms.
• Challenges: sleep disruption, vivid dreams, dizziness, dry mouth, skin changes, urinary retention in some.

Patient Diary Template: date | time of dose | dose taken | perceived benefit (0–5) | side effects noted | notes for GP.

Patients are advised to bring this diary to reviews every 3–6 months with the GP or neurologist.

Buying Guide

Where can Symmetrel be dispensed in the UK and what are the likely costs?

Pharmacy Sources (Boots, LloydsPharmacy, Superdrug)

Symmetrel (amantadine hydrochloride) is dispensed on prescription via Boots, LloydsPharmacy, Superdrug and independent community pharmacies.

Online pharmacies that are GPhC‑registered may dispense after verifying a valid prescription.

Brand availability depends on supplier contracts; some regions may supply generic presentations rather than a branded product.

Price Comparison (NHS Prescription Charge Vs Private)

On the NHS, prescriptions are free in Scotland, Wales and Northern Ireland; England usually applies a per‑item charge — check NHS guidance for current fees.

Private prescriptions vary in cost between pharmacies and online sellers; ask your pharmacist about generic alternatives to reduce expense.

Note: In our online pharmacy, symmetrel is available without a prescription, with discreet delivery to United Kingdom in 5–14 days.

What’s Inside And How It Works

What does Symmetrel contain and how does it improve Parkinson’s symptoms?

Ingredients Overview

The active ingredient is amantadine hydrochloride (INN).

Typical tablet strength is 100 mg; syrup formulations are 50 mg/5 mL in markets where supplied.

Excipients differ by manufacturer — always read the patient information leaflet if you have known excipient sensitivities.

Mechanism Basics Explained Simply

In Parkinson’s, amantadine appears to increase dopamine release and acts as an NMDA receptor antagonist, which can improve mobility and reduce dyskinesia.

Historically as an antiviral for Influenza A, it blocks the viral M2 ion channel, but resistance has limited routine influenza use.

Main Indications

What is Symmetrel licensed to treat, and when is its use off‑label?

Approved Uses (MHRA Listing)

Licensed indications include Parkinson’s disease (idiopathic and some secondary forms) and drug‑induced extrapyramidal symptoms.

It has also been used historically for treatment and prophylaxis of Influenza A, though resistance limits routine seasonal use.

Certain extended‑release formulations in other markets are licensed for levodopa‑induced dyskinesia.

Off‑Label Uses In UK Clinics

Off‑label uses reported include management of fatigue in multiple sclerosis and post‑viral fatigue syndromes, and use in some post‑brain injury rehabilitation settings.

Evidence for off‑label indications is mixed and specialist input is recommended before prescribing.

Interaction Warnings

Which foods and medicines can make Symmetrel more risky?

Food Interactions (Alcohol, Tea/Coffee)

No major food interactions with typical UK foods are documented, but alcohol can worsen dizziness, sedation and confusion when combined with amantadine.

High caffeine intake from tea or coffee may increase nervousness or sleep disruption in sensitive individuals taking amantadine.

Drug Conflicts (MHRA Yellow Card Reports)

Amantadine interacts with other CNS‑active drugs, increasing the risk of confusion or hallucinations when combined with anticholinergics or some antipsychotics.

Agents that lower seizure threshold such as bupropion or tramadol require caution; antihypertensives may increase orthostatic hypotension risk.

Before starting or adding medication, review interactions and report suspected adverse drug reactions via the MHRA Yellow Card system.

• High‑Risk Drug Classes: anticholinergics, antipsychotics, bupropion, tramadol, certain antihypertensives, MAO inhibitors — consult pharmacist or prescriber.
• Interaction Checklist For Pharmacy: review current medicines, check renal function, advise on driving and dizziness risks, document counselling.

Latest Evidence And Insights

What does recent research say about amantadine’s role in Parkinson’s and fatigue?

Systematic reviews up to 2024 continue to show amantadine has utility for selected Parkinson’s symptoms and for reducing levodopa‑induced dyskinesia in appropriate patients.

Extended‑release formulations have trial evidence supporting dyskinesia benefit in certain markets, though availability varies by region.

Evidence for fatigue in multiple sclerosis or post‑COVID conditions is mixed; small trials and observational studies report variable and sometimes transient benefit.

For influenza, rising viral resistance has curtailed routine antiviral use of amantadine; local public‑health guidance should guide antiviral selection.

Clinical Takeaway: use amantadine as a niche, specialist‑guided option and consult NICE, MHRA and local formulary guidance before changes to therapy.

Alternative Choices

What other medicines might a GP or neurologist try instead of Symmetrel?

For Parkinson’s motor control the principal alternative is levodopa/carbidopa which remains the most effective agent, though it can cause dyskinesia with long‑term use.

Dopamine agonists such as pramipexole or ropinirole offer adjunctive benefit but carry risk of impulse control disorders; MAO‑B inhibitors like selegiline or rasagiline are milder adjuncts.

For antiviral coverage against Influenza A, rimantadine is another adamantane derivative but local resistance patterns influence suitability.

Pros/Cons Checklist

• Levodopa/Carbidopa: high efficacy for motor symptoms; risk of long‑term dyskinesia; routine monitoring.
• Dopamine Agonists: effective adjuncts; watch for behavioural side effects; consider in younger patients without cardiac/psychiatric risk.
• MAO‑B Inhibitors: modest benefit; generally well tolerated; useful as combination therapy.
• Rimantadine: antiviral alternative in some settings; check resistance and local guidance.

Quick Decision Checklist For Consultations: list main symptom to treat, prioritise safety (age, renal/psychiatric history), compare likely benefit and side‑effect profiles, discuss cost and monitoring with the patient.

Regulation Snapshot

How is Symmetrel regulated and what should patients expect when getting it on repeat?

MHRA Approval & NHS Prescribing Framework

Amantadine hydrochloride is an MHRA‑authorised substance presented under various brand and generic names and is prescription‑only across the UK.

Local NHS formularies decide on brands or generics to be used; certain extended‑release brands are regionally available and may have specific licensing for dyskinesia.

Practical Notes For Patients

Prescriptions and repeat supplies follow standard NHS processes — check with your GP practice for repeat‑prescription arrangements and whether electronic repeat or the NHS app is suitable.

Pharmacists must supply only with a valid prescription and online pharmacies must be registered and verify identity and prescription prior to supply.

For safety concerns or suspected defective medicines contact the MHRA and your supplying pharmacist.

Flowchart: Prescription → Pharmacy Dispensing (verification) → Supply → Report adverse reactions via Yellow Card or contact MHRA/pharmacist.

FAQ

What quick answers do patients commonly need about Symmetrel?

• Can I drive while taking Symmetrel? Only if you are not experiencing dizziness, drowsiness, confusion or seizures; notify the DVLA if new seizures or loss of concentration occur and consult your prescriber.
• Will it help if I have flu now? Amantadine can treat Influenza A if started within 48 hours, but resistance limits routine use and current public‑health guidance often recommends other antivirals — check with NHS 111 or your GP.
• What should I do about vivid dreams or hallucinations? Report these to your GP or pharmacist promptly; dose reduction or stopping may be required and alternative therapies should be considered.
• How do I get repeats? Request an electronic repeat via your GP practice or the NHS app; speak to your community pharmacist for help with prescription queries and urgent needs.

Support Groups: Parkinson’s UK and the MS Society are good places to seek peer support and condition‑specific advice.

Guidelines For Proper Use

What should pharmacists say when counselling someone starting Symmetrel?

UK Pharmacist Counselling Style

Confirm the indication, dose and formulation and explain expected start‑up effects and common side effects such as sleep changes, blurred vision and dry mouth.

Advise on what to do for a missed dose, storage (15–30°C, protect from light) and check for renal impairment, psychiatric history and interacting medicines.

Offer written information and a follow‑up plan within 1–2 weeks of starting treatment to check tolerability and benefit.

NHS Patient Support Advice

Signpost to Parkinson’s UK, MS Society, local neurology clinics and community pharmacist services.

Encourage patients to keep symptom diaries of motor benefit, sleep and mood, bring medicines to appointments and report adverse reactions via the MHRA Yellow Card.

Return unused medicines to any NHS pharmacy for disposal.

• One‑Page Counselling Checklist: indication | dose | expected benefits | side effects to watch | driving/work advice | follow‑up date.

Delivery Across United Kingdom